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Abstract: Studies have shown that creatine supplementation increases intramuscular creatine
concentrations, favoring the energy system of phosphagens, which may help explain the observed
improvements in high-intensity exercise performance. However, research on physical performance
in soccer has shown controversial results, in part because the energy system used is not taken into
account. The main aim of this investigation was to perform a systematic review and meta-analysis to
determine the efficacy of creatine supplementation for increasing performance in skills related
to soccer depending upon the type of metabolism used (aerobic, phosphagen, and anaerobic
metabolism). A structured search was carried out following the Preferred Reporting Items for
Systematic Review and Meta-Analyses (PRISMA) guidelines in the Medline/PubMed and Web
of Science, Cochrane Library, and Scopus databases until January 2019. The search included studies
with a double-blind and randomized experimental design in which creatine supplementation
was compared to an identical placebo situation (dose, duration, timing, and drug appearance).
There were no filters applied to the soccer players’ level, gender, or age. A final meta-analysis
was performed using the random effects model and pooled standardized mean differences (SMD)
(Hedges’s g). Nine studies published were included in the meta-analysis. This revealed that creatine
supplementation did not present beneficial effects on aerobic performance tests (SMD, −0.05;
95% confidence interval (CI), −0.37 to 0.28; p = 0.78) and phosphagen metabolism performance
tests (strength, single jump, single sprint, and agility tests: SMD, 0.21; 95% CI, −0.03 to 0.45; p = 0.08).
However, creatine supplementation showed beneficial effects on anaerobic performance tests (SMD,
1.23; 95% CI, 0.55–1.91; p <0.001). Concretely, creatine demonstrated a large and significant effect
on Wingate test performance (SMD, 2.26; 95% CI, 1.40–3.11; p <0.001). In conclusion, creatine
supplementation with a loading dose of 20–30 g/day, divided 3–4 times per day, ingested for 6 to
7 days, and followed by 5 g/day for 9 weeks or with a low dose of 3 mg/kg/day for 14 days presents
positive effects on improving physical performance tests related to anaerobic metabolism, especially
anaerobic power, in soccer players.
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1. Introduction
Creatine (Cr) is one of the most used ergogenic nutritional aids by athletes. Studies have shown
that the effective dose for Cr supplementation of 0.3 g/kg/day for 5–7 days, followed by a maintenance
dose of 0.03 g/kg/day (most commonly for 4–6 weeks) [1], increases intramuscular phosphocreatine
(PCr) concentrations by favoring phosphagen metabolism [2]. This may help explain the observed
improvements in the performance of high-intensity exercises that lead to greater training adaptations [3,4].
Likewise, Cr supplementation has been shown to increase the glycogen replenishment rate, which may
help those athletes who perform at prolonged submaximal effort (65–75% peak of the maximum rate
of oxygen consumption − VO2max) [5] or engage in repeated high-intensity exercises [6,7], in relation
to aerobic and anaerobic metabolism, respectively. In this line, there are many sports modalities,
the practice of which involves a combination of high-intensity actions, in isolation or repeatedly,
where optimal anaerobic metabolism is necessary, and low-intensity actions, where efficient aerobic
metabolism is necessary [8].
Among them, in particular, soccer is characterized by combining high-intensity activities, such as
sprinting, running, jogging, accelerating, jumping, and changing direction, with low-intensity phases
(stopping or walking) [9]. The average distance covered by players during a soccer match is between
8 and 12 km [10], where they perform between 50 and 250 high-intensity actions [11] that represent
about 1–12% of the total distance covered [12]. In this sense, during the high- and maximum-intensity
phases, the energy that a player gets is obtained through anaerobic processes (both phosphagen and
anaerobic metabolism), whereas during the general effort of a soccer match (90 or 120 min), it is
obtained aerobically [13]. Therefore, having substrates that provide the necessary energy in each phase
seems to be an objective to obtain maximal performance [14].
There have been numerous studies focusing on the effects of Cr supplementation on physical
soccer performance, with mixed results. Thus, while Biwer et al. [15] and Williams et al. [16] showed
possible benefits for aerobic performance, other authors did not find these benefits [17–19]. Similar
results have been observed regarding tests that use phosphagen metabolism. In this case, while there
are several studies that have observed potential positive effects of Cr supplementation on this type of
metabolism [6,18,20], Ramírez-Campillo et al. [19] and Williams et al. [16] did not find any benefits for
the performance of individual actions, such as a single jump or a sprint. However, all of the studies
that have focused on the effect of Cr supplementation in relation to anaerobic metabolism, such as
repeated sprints [17,19,21] or the Wingate test [6,7], showed possible beneficial effects, although the
final effect on soccer athletic performance is unknown, given that some of these benefits are rather
small [17,19,21].
Although Cr could improve soccer athletic performance, to the best of the authors’ knowledge,
there is no clear consensus on the kind of soccer skills, and therefore the energy system involved,
for which Cr supplementation could be more effective. Moreover, there is some controversy regarding
the doses, duration, and timing. Hence, unifying the data of these different studies would support the
soccer world by making it possible to apply this knowledge over the course of a season. Therefore,
we proposed carrying out a systematic review and final meta-analysis of the relevant articles published
in the scientific literature, the main aim of which is to discern the potential effects of Cr on soccer athletic
performance depending on the metabolic energy system used (aerobic, phosphagen, and anaerobic
metabolism). Thus, this systematic review and meta-analysis presents current information on the
effects of Cr on soccer athletic performance. In addition, it shows the effective doses and ideal moment
of its intake.
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2. Methods
2.1. Searching Strategies
The present article is a systematic review with a meta-analysis focusing on the effect of Cr or Cr
monohydrate on soccer performance. It was carried out following the Preferred Reporting Items for
Systematic Review and Meta-Analyses (PRISMA) guidelines, which helped to improve the integrity of
this review [22]. The PICOS model was used to determine the inclusion criteria [23]—P (Population):
“soccer players”, I (Intervention): “creatine supplementation”, C (Comparators): “same conditions
with placebo”, O (Outcome): “soccer-specific skills and relationships with aerobic, phosphagen,
and anaerobic metabolism performance”, and S (study design): “double-blind and randomized design”.
A structured search was conducted in the following databases: PubMed/MEDLINE, web of
science (WOS), Cochrane Library, and Scopus. It included results until 30 January 2019, while no year
restriction was applied to the search strategy. Search terms included a mix of medical subject headings
(MeSH) and free-text words for key concepts related to Cr and soccer performance. Specifically,
we used the following search equation: (“football” [All Fields] OR “soccer” [All Fields]) AND “creatine
supplementation” [All Fields] AND (“physical performance” [All Fields] OR “physical endurance”
[All Fields] OR “physical” [All Fields] OR “endurance” [All Fields] OR “performance” [All Fields]
OR “aerobic” [All Fields] OR “anaerobic” [All Fields]), which returned relevant articles in the field of
applying the snowball strategy. All titles and abstracts from the search were cross-referenced to identify
duplicates and any potential missing studies. Titles and abstracts were screened for a subsequent
full-text review. The search for published studies was independently performed by two different
authors (JMA and JCG) and disagreements were resolved through discussions between them.
2.2. Inclusion and Exclusion Criteria
There were no filters applied to the soccer players’ level, gender, race, or age to increase the power
of the analysis. However, for the articles obtained in the database search, the following inclusion criteria
were applied to select the final studies: (1) in which there was an experimental condition that included
the ingestion of Cr before and/or during exercise which was compared to an identical experimental
condition with the ingestion of a placebo; (2) testing the effects of Cr on soccer-specific tests and/or real
or simulated matches; (3) with a blinded and randomized design; (4) with clear information regarding
the administration of Cr (relative dose of Cr per kilogram of body mass and/or absolute dose of Cr
with information about body mass, timing of Cr intake before the onset of performance measurements,
etc.); (4) on soccer players with previous training backgrounds in this sport; and (5) published in
any language. On the other hand, the following exclusion criteria were applied to the experimental
protocols of the investigation: (1) studies that were not conducted with soccer players; (2) studies that
were performed for clinical purposes or therapeutic use; (3) the absence of a true placebo condition;
and (4) studies carried out using participants with a previous medical condition, illness, or injury.
2.3. Data Extraction
Once the inclusion/exclusion criteria were applied to each study, data on study source (including
authors and year of publication), study design, Cr supplementation (dose and timing), sample size,
characteristics of the participants (level and gender), and final outcomes of the interventions were
extracted independently by two authors using a spreadsheet. Subsequently, disagreements were
resolved through discussion until a consensus was achieved.
Experiments were clustered by the type of test used to assess team sport performance, and groups
of experiments were created which assessed the effect of Cr on aerobic performance (Yo-Yo intermittent
recovery test level 1), phosphagen metabolism performance (strength, jump, sprint, and agility course),
and anaerobic metabolism measures (repeated sprint ability and the Wingate test). Six studies included
measurements of two or more types of performance outcomes (e.g., aerobic and phosphagen abilities)
or even two types of tests for the same performance outcome. In these cases, each test or type of
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performance outcome was treated as a single and independent set of data for the meta-analysis and
included in the appropriate performance outcome.
The mean (M), standard deviation (SD), and sample size data were extracted by one author from
the tables of all of the included papers (DMJ). Whenever necessary, we contacted the authors to obtain
the data. When it was impossible, mean and SD were extrapolated from the figures. Any disagreement
was resolved by consensus (JMA and DMJ) or third-party adjudication (JCG).
2.4. Quality Assessment of the Experiments
Methodological quality and risk of bias were assessed by two authors independently (JMA and
DMJ), and disagreements were resolved by third-party evaluation (JCG), in accordance with the
Cochrane Collaboration Guidelines [24]. The items on the list were divided into different domains:
random sequence generation (selection bias), allocation concealment (selection bias), blinding of
participants and personnel (performance bias), blinding of outcome assessment (detection bias),
incomplete outcome data (attrition bias), selective reporting (reporting bias), and other types of bias.
They were characterized as “low” if criteria for a low risk of bias were met (plausible bias unlikely
to seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that
seriously weakens confidence in the results). If the risk of bias was unknown, it was considered
“unclear” (plausible bias that raises some doubts about the results). Full details are given in Table 1
and Figure 1.
Table 1. Risk of bias graph: review of authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Th y were chara terized as “lo ” if criteri  for a low risk of b as were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weake s co fid nce in the results). If the ri k of b as was u known, it was considered 
“unclear” (plausible bias that raises some doubts abou  h  results). Full details are giv n in Table 1 
and Figure 1. 
T ble 1. Risk f bias g aph: review of authors’ judgem nts about each risk of bias i m presented as 
percentages acro s all included studies. indicates low risk of bias,  indicates unknown risk 
of bias, and  indicates high risk of bias. 
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2.4. Quality Assessment f th  Expe im nts 
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participants and personnel (performance bias), bli ding of outcome assessment (detection bias), 
incomplete outcome data (attrition bias), s l ctive reporting (reporti g bias), and other types of bias. 
Th y were chara terized as “lo ” if criteri  for a low risk of b as were met (plausible bias unlikely to 
seriously alter the results) or “high” if c iteri  f r a high risk of bias were met (plausible bias that 
seriously weakens c nfidence in the results). If the risk of b as was u known, it was considered 
“unclear” (plausible bi s that raises some doubts about he results). Full details are given in Table 1 
and Figure 1. 
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2.4. Quality A e sme t of the Expe im nts 
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random s quence generati  (selectio  bias), allocat on concealment (selection b as), blinding of 
a ticip t  d personnel (p rformance b a ), blinding of utco assessment (detection bias), 
incomplete out om  data (attrition b as), selectiv reporti g (report g bias), and other types of bias. 
They were characterized as “low” if riteria for  low risk f ias were met (plausible bias unlikely to 
ser ously alter the results) or “high” if crit ria f r a high risk of bias were met (plausible bias that 
seriously weake s c fid nce in the res lts). If the risk of bias was unknown, it was considered 
“unclear” (pl usible bias that is s some doubts abou  the r sults). Full details are giv n in Table 1 
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C c ran  C llaborat o  Guidelines [24]. The it ms on th list w re divi ed i to iffere t domains: 
ra dom sequ n e ge er tion (sel ction bi s), all cation c cea ment (selecti n bias), blinding of 
participants a d personnel (p rformance bias), bl nding of outcome assessment (detection bias), 
incomplete ou come dat (attrition bias), s lective r porting (reporting bias), and other types of bias. 
Th y were har te ized as “lo ” if criter for a low risk of b as were met (pl usib e bias unlikely to 
se iously alter the e ults) or “h gh” i  criter a for a high isk of bias were met (plausible bias that 
seriously weakens confi ence in the r su ts). If the ri k of b as was u known, it was considered 
“unclear” (pl sibl bias that raises some doubts abo t h results). Full details are given in Table 1 
and Figure 1. 
T ble 1. Ri k f b as g ap : evi w of uth rs’ judgeme ts about each r sk of bias item presented as 
per ent ges acro  ll included stu ies. indicates low risk of bias,  i dicates un nown risk 
of bias, and  indicates high risk of bias. 
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the data. hen i  as i possible, ean nd SD ere extrapolated fr  the figures. Any 
disagree ent as re olv d by consensus (J A nd D J) or hird-pa ty a judicat on (JCG). 
2.4. Quality A se sme t of the Expe im nts 
etho ological quality and risk of bias ere assess  by t o author  independently (J A and 
D J), and disagre ents ere re olved by thir -party valua io  (JCG), in ccordance ith th
C chran  Co laborati n Guideli es [24]. The ite s on the list r  divided i to i ferent o ai s: 
rando  sequence generation (s lection bias), a location c nce l ent (se ection bias), blinding of
participants and personnel (perfor ance bias), blinding of outco e assess ent (detection bias), 
inco plete utco data (a trition b as), s lective repor ng (repo ting bi s), and other types of bias. 
They ere characterized s “ ” if criteri for a lo risk of bias ere et (plausible bi s un ikely to 
seriously alter the r sults) o  “hig ” if crit ria or a gh risk of b as ere e (plausible bi s that
seriously eakens c nfidence in the r sult ). If the risk of bias as unkno n, it as considered
“unclear” (plausible bi s that raise  so  doub s bout the res lts). Fu l details are given in Table 1 
and Figure 1. 
Table 1. Risk of bias graph: r v ew of authors’ jud ements about e ch risk of bias tem presented s 
perce t ges a ro s a l in lude  tu ies.  nd cates low risk of bias,  indicates u known r s  
of bias, and  indicates high risk of bias. 
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The me n (M), standard deviation (SD), and s mple siz  data w re extracted by one author from 
the t ble  of all of the i cluded pap s (DMJ). Whenever necessary, we contacted the authors to obtain 
h  data. Wh it was im ssible, m n and SD were extrapolated from the figures. Any 
di agr me t was resolve by consensus (JMA and DMJ) or third-party adjudication (JCG). 
2.4. Quality A ment f th  Ex e im ts 
Methodological quality nd risk of bias re assessed b two authors independently (JMA and 
DMJ), and is greements we e resolv d by hird-party evaluat on (JCG), in accordance with the 
Cochran  Collaborati n Guide nes [24]. The it ms n th  li wer  divi ed into different domains: 
random s qu nce generation (selection bia ), allocatio  concealment (selection bias), blinding of 
particip nts a  perso nel (perf rmance bias), blinding of outcome assessment (detection bias), 
incomplet  utc me data (a r tion bias), elective rep rting (reporting bias), and other types of bias. 
They w re characterized as “l w” if criteri  for a low ris  of bias w re met (plausible bias unlikely to 
s riou ly lter t e results) or “hig ” if c iteri  for a h gh risk of bias were met (plausible bias that 
s riou ly weaken c fidence in the results). If the ri k of bias as unknown, it was considered 
“uncl ar” (plausible bi  tha  r ises some doub s about the results). Full detai s are given in Table 1 
and Figure 1. 
Ta le 1. Risk f bia  graph: r view of u hors’ judgemen  bout e ch of bias item presented as 
percent g across ll i cluded stud e .  i i low risk of bias,  ndicates unknown risk 
of bias, and  indicates high risk of bias. 
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The mean (M), stan ard deviation (SD), d sample size ata were extracte  by one author from 
the tables f all of the included papers (DMJ). Whe ever necessary, we contact d t e auth rs t  obtain 
the data. When it was impossible, mean a d SD were extrapolated from the figures. Any 
disagreeme t was resolved by consensus (JMA and DMJ) or third-party adjudication (JCG). 
2.4. Quality Assessment  the Exp iment  
Methodologic l qu lity and risk of bias were assessed by two authors in ependently (JMA and 
DMJ), and disagreements were resolved by third-party evaluation (JCG), in accordance with the 
Cochra e C llaboration Guidelines [24]. The items on t e list were divi ed into different domains: 
random sequence generatio  (selection bias), allocation c cealme t (selection bias), blinding of 
particip ts and personnel (performance bias), bli di g of outco e assessment (detection bias), 
incomplete outco e data ( ttrition bias), sele tive reporting (reporting bias), and other types of bias. 
They ere characterized as “low” if criteri  f r a low risk of bias ere met (plausible bias unlikely to 
seriously alter the results) or “ igh” if criteri  for a high risk of bias wer  met (plausible bi s that 
seriously weake s co f de ce in the results). If the risk of bias was unknow , it was considere  
“unclear” (pla sible bias that raises some doubts about the results). Full details are given in Table 1 
and Figure 1. 
Table 1. Risk of bias graph: review of authors’ judgements about each risk of bias item presented as 
percentages across all included stu ies.  indicates low risk of bias,  indicates u kno  risk 
of bias, and  indicates high risk f i s. 
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The me  (M), sta ard deviation (SD), a  sampl size data were extracted by one author from 
the tables f all of th included papers (DMJ). Whenever nec ssary, we cont cted the authors t  btain 
the data. When it as impossible, mean a d SD were extrap lated from the figures. Any 
disagreem nt was resolved by co sensus (JMA a  DMJ) or hir -party adjudication (JCG). 
2.4. Qu lity Asses ment  th  Exp imen  
Methodological quality and risk of bia  w re assessed by two authors indepe ently (JMA and 
DMJ), a d disagreements were resolve  by hir -par y evaluation (JCG), in accordanc  with the 
Cochra e C llaboratio  Guidelines [24]. The items o  th list w re divi ed into iffere t omains: 
random sequ nce ge eration (selection bi s), all cation c cea ment (selectio  bias), blinding of 
participa ts a d perso el ( erforma ce bias), blinding of outcome assessment (detection bias), 
incomplet outcome d ta (attr ti  bias), s lective reporting (reporting bias), and other types of bias. 
They were char cterized as “l w” if criteria for  low risk of bias were met (pl usib e bias unlikely to 
seriously alter t e esults) or “h gh” i  criter a f r a high risk of bias were met (pl usible bias that 
s riously weake s co fide ce in t e results). If the risk of bias was unknow , it was considere  
“unclear” (pl usible bias that raises s me doubts abo t the results). Full details are given in Table 1 
and Figur  1. 
Table 1. Risk of bias grap : review of authors’ judgements about each risk of bias item presented as 
per entages across all include  stu ies.  indicates low risk of bias,  i dicates un now  risk 
of bias, and  indicate  high risk of bias. 
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The mean (M), standard deviation (SD), and sample size data were extracted by one author from 
the tables of all of the included papers (DMJ). Whenever necessary, we contacted the authors to obtain 
the data. When it was impossible, mean and SD were extrapolated from the figures. Any 
disagreement was resolved by consensus (JMA and DMJ) or third-party adjudication (JCG). 
2.4. Quality Assessment f th  Expe iments 
Methodological quality and risk of bias were assessed by two authors independently (JMA and 
DMJ), and disagreements were resolved by third-party evaluation (JCG), in accordance with the 
Cochrane Collaboration Guidelines [24]. The items on the list were divided into different domains: 
random sequence gen ration (selectio  bias , all cation concealment (selection bias), blinding of 
participants and personnel (performan  bias), blinding of outcome ssessment (detection bias), 
incomplete outcome data (attrition bias), selective reporting (reporting bias), and other types of bias. 
They were characterized as “low” if criteria for a low risk of bias were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the results). If the risk of bias was unknown, it was considered 
“unclear” (plausi le bias that raises s me d ubts about t e results). Full details are given in Table 1 
and Figure 1. 
Tabl  1. Risk of bias graph: r view of author ’ j geme ts ab ut each ris  f i s it m pr ented s 
percent ges across all inclu e  studies.  indic tes low risk of bias,  indicates unknown risk 
of bias, and  indicates high risk of bias. 
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The mean (M), standard deviation (SD), and sample siz da a w re extracted by one author from 
the tables of al  of the included papers (DMJ). Whenever necessary, we contacted the authors to obtain 
the data. When it was impossible, mean and SD were xtrapolated from the figures. Any 
disagreement was res lved by consensus (J A and DMJ) or third-party adjudication (JCG). 
2.4. Quality A sessme t of the Expe im nts 
Methodologic l quality and risk of bias were assessed by two authors i dependently (JMA and 
DMJ), and disagre ments w re resolved by third-p rty evaluatio (JCG), i  accordance with the 
chrane Collaboration Guidelin s [24]. The it m  on the l st were divided i to different domains: 
random s quence g nerati  (selection bias), allocation concealment (selection b as), blinding of 
participant  a d personnel (p rformanc  b as), blinding of outco  assessment (detection bias), 
incomplete outcome data (attrition b as), selective reporting (reporti g bias), and other types of bias. 
They were characterized as “low” if criteria for a low risk of bias were met (plausible bias unlikely to 
seriously alter he results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weak s c fid nce in the re ults). If the risk of bias was unknown, it was considered 
“unclear” (plausible bias that raises s me doubts ab u  t e results). Full etails are giv n in Table 1 
and Figure 1. 
Table 1. Ri k of b s gr ph: r vi w of a thors’ judgem n s about each r sk of bias i m prese ted as 
percent ge  across all i cluded studies.  ndicates low risk of bias,  indicates unknown risk 
of bias, and  indicates high risk of bias. 
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The mean (M), standard deviation (SD), a d sample size data were extracted by on  auth r from 
the tables of all of the included papers (DMJ). Whenev  n cessa y, we contact d the authors to obtain 
the data. When i  was i pos ible, mean and SD were extrapolated from the figures. Any 
disagreement was re olv d by consensus (JMA and DMJ) or third-party adjudicat on (JCG). 
2.4. Quality Assessment of the Experiments 
Methodological quality and r sk of bias were assessed y t o author  independently (JMA and 
DMJ), and disagreements wer  resolved by third-party valua ion (JCG), in ccordance with the 
Cochrane Coll boration Guidelines [24]. The items on he list were divided into ifferent omai s: 
random sequence generation (s lection bias), alloc tion c ncealment (selection bias), blinding f
participants and personnel (p rf rmanc  bias), bli ding of outco e assessment (detection bias), 
incomplete utcome data (attrition bias), selective r porting (reporting bias), and other types of bias. 
They were charact rized as “low” if criteria o  a l w risk of bias were me  (plausible bias unlikely to 
seriously alter the r sul s) or “hig ” if crit ria fo  a igh i k f bia  were met (plausible bia  that 
seriously weakens confiden e in the results). If the risk of bia was unknown, it as co sidered
“unclear” (plausible bias t at rai e  s m  d ub s b t he resul s). Full details are given in Table 1 
and Figure 1. 
Table 1. Risk of bias gr ph: rev ew of authors’ judgeme ts bout e ch r sk of bias item pre ented s 
perce tages across all in luded tu ies.  ind cates low risk of bias, indicates unknown r sk 
of bias, and  indicates high risk of bias. 
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The e  ( ), st dard deviation (SD), and sa ple size data ere extracted by one author fro  
the tables of a l of the included papers (D J). henever nec ssary, e cont cted the u hors to obtain 
the data. hen it as i possible, ean and SD ere extrap lated fr  the figures. Any 
disagree nt as resolved by consensus (J A and D J) or hir -pa ty a judication (JCG). 
2.4. Quality A se sment of th  Expe i nts 
ethodological quality and risk of bia  ere assess d by t o authors independently (J A and 
D J), and disagree ents ere re olve by hir -party evalua ion (JCG), in accordanc  ith th
Cochrane C laborati  Guideli es [24]. The ite s on th lis  r  divided into i ferent o ai s: 
rando  sequ nce generation (s lectio  bias), a l cation c ncea ent (se ection bias), blinding of 
participants a d pers nnel (perfor anc  bias), blinding of outco e ssess ent (detection bias), 
inco plet ou co  data (a trition bias), sele tive repor ng (reporting bias), and other types of bias. 
They ere char cterized s “lo ” if criteria for a lo risk of bias ere et (pl usib e bi s un ikely to 
seriously alter the esults) o  “h gh” i  criter a or a h gh risk of bias ere et (plausible bi s that
seriously eakens confidence in the r sults). If the risk of bias as unkno n, it as considered 
“unclear” (pl usible bi s that r ises s  d ubts abo t the r s lts). Fu l det ils are giv  in Tabl  1 
and Figure 1. 
Table 1. Risk of bi s graph: r view of thors’ jud emen s ab ut e ch risk of bias tem presented s 
per ent ges a ro s a l in lude  stu ies.  ind cates low risk of bias,  i dicates u nown ris  
of bias, and  indicates high risk of bias. 
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seriously weakens confidence in the re ults). If the risk of bias was unknown, it was considered 
“unclear” (plausible bi s hat r is s me oubts abou  th r ults). Full det il are g ven in Table 1 
and Figure 1. 
Table 1. Risk of bias gr ph: r vi w of authors’ j gements about ea h risk of bias ite  present d as 
percent ges across all included studies.  indicates low risk of bias,  indicates u known r sk 
of bias, and  indicates high risk of bias. 
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The me  (M), standard deviation (SD), and sample size data were extracted by one author from 
the tables of all of the included papers (DMJ). Whenever ec sary, we cont cted t  author to obtai  
the data. When it was impossible, mean and SD we  extrap la ed from the figures. A y 
disagr em nt was resolved by consensus (JMA and DMJ) or hir -party judication (JCG). 
2.4. Quality Assessme t f th  Ex im nts 
Method logic l qu li y  r sk of ia  w  assess d y two authors i d pe ntly (JMA and 
DMJ), and is gre ents were r s l  by hird-p r y valu tio  (JCG), in accorda c  with he 
Cochr ne C llaboratio  Guid lines [24]. Th t ms o  th l st w r  divi d int if r  dom n : 
random seq nc  gen ration ( lecti n bi s), a l cation c nc a ment (selecti n i ), blinding of
participant  a  personn l (p rf rmanc  bias), bli ing of outcome as ssment ( t ctio  bi ), 
incomplet ou come d t ( ttrition bias), l ctiv  r p rting (rep rting ias), and oth r typ s of bias. 
They were characterize s “low” if crit ria for a low risk of bias were met (pl usib e bias unlikely to 
seriously alter the esults) or “h gh” i  criter a for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the re ults). If the ri k of bias was unknown, it was considered 
“uncle r” (pl usi bi s hat rai me oubts bo t e r sults). Ful  d t ils a e given in Ta le 1 
and Figure 1. 
Table 1. Risk of bias graph: r vi w of authors’ judg me ts about e ch i f i s item prese t d as 
per ent ges acros  ll include  studies.  indicate  low risk of bias,  i dicates un nown r sk 
of bias, and  indicates high risk of bias. 
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The mean (M), standard deviation (SD), a  sample size data were extracte  by on  auth r from 
the tables of all of the included papers (DMJ). When ver n c ss y, we contact d the authors o obtain 
the data. When it was impos ible, ean and SD er  extrapolat d from he figures. An  
disagreement was resolved by conse s s (JMA and DMJ) or third-party adjudication (JCG). 
2.4. Quality Assessmen  of the Exper me  
Methodological quali y and r sk of bi s were ass ed by t o uthor  i depe d ntly (JMA and 
DMJ), and disagreements wer  resolv d by thir -p rty evaluati  JCG), in a c rdan e with the 
Cochrane Coll boration Guidelines [24]. The t ms on e li t were divid d into ifferent domai s:
random sequence generation (select n bi s), alloc tion oncealment (sele tion bias), blinding of 
participants and ersonnel (performance bias), b in i g of outcom  assessm t (d t c ion i s), 
incomplete utcome data (attrition bias), selec ive r port ng (reporting bias), and ther type of bias. 
They were charact rized as “low” if c iteria o  a low risk of bias were met (plausible bias unlikely to 
seriously alter the resul s) or “high” if criteria fo  a high isk of bia  were met (plausible bia  that 
seriously weakens confiden e in the results). If the risk of bia  was unkn wn, it  consider d 
“unclear” (plausible bias that r i es ome oubt  e r l ). F etails ar  g ven in Tabl 1
and Figure 1. 
Table 1. Risk of bias graph: review f uthors’ judgeme ts about ea h risk f bi s it m re ented as 
percentages across all include  studies.  in icates low risk of bias, in icates unknown risk 
of bias, and  indicates high risk of bias. 
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The mean (M), standar  devi tion (SD), and sample iz da a w r  extracted by one author from 
the tables of l  of the includ d papers (DMJ). Wh n v r nec ss ry, we c ntacted th uthors t  obtain 
the data. When it was i po sible, mean and SD ere xtrapolat  from the figures. Any 
disagreement was res lved by consensus (J A nd DMJ) or third-party adjudication (JCG).
2.4. Quality Ass ssmen  of th  Exper e  
Methodologic l quality and ri k of bias were sse sed by two authors i epen e tly (JMA and 
DMJ), and dis gre ments w re r s lv d by thir -p r y ev luati (JCG), i  acco dan e with the
chrane Collaboration Guidelin s [24]. The it m on the l st ere div ded i to diff r nt do ins: 
random s quence generati  (s l ction bi s), allocation concealme t (s l cti n b s), blinding of
participant  a d pers nel (p rformance b as), blindi  of utco as essment (det c i bias), 
i complete o tcome data (attr tion s), s lective reporting (reporti g bias), and oth r types of bias. 
They were characterized as “low” if criteria for a low risk f bias were met (plausible bia  nlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weake s co fid nce in the results). If the risk of b as was unknow , it was consider d 
“unclear” (plausible bias th t rai e  s me oubt abo  t e re ults). Full det l ar  g v  in Ta le 1
and Figure 1. 
Table 1. Risk f bia  graph: review f authors’ jud em nts ab ut ea h risk f bia  i m prese ted s 
percentag s across all inclu e  studies.  ndicates low risk of bia ,  ndicates unknown r sk
of bias, and i icates high risk of bias. 
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Th  me n (M), stand d d viati  (SD), a d sample size data were extracted by one author from 
the ables of all of th  nclud d pap rs (DMJ). Whenever nece ary, we contact d the authors to obtain 
th  data. Wh n it w s im ssible, ean and SD were xtrapolated from the figures. Any 
isagreeme  was resolve  by onsensus (JMA and DMJ) or thir -party adju icatio  (JCG). 
2.4. Qua ity A se sme t f th  Expe iments 
M tho l gic l qu lity and ri k of ias w r asses ed by two uth rs ind pendently (JMA nd 
DMJ), nd i gre ments w re res l e  by t rd-pa y valu ion (JCG), i  accordance with the 
Co r n  Collabo at on Gu d lines [24]. Th  it m on t  l st w r  divid d i t  diff r nt domain : 
andom seq enc  g er ti n (sel tio  ia ), all cat on conc lm nt ( lection i s), blinding of 
a ticip ts per nn l (p rfo mance bia ), bl di g of utcome as essment ( e ection bias), 
incomplet out m  ata ( ttr tion bi s), s lecti  r porting (report ng bias), and th r types of ias. 
They were characterized as “ ow” if cr ter a for a low is  of bias were met (plausible bias unlikely to 
se iously alter t e re ults) or “high” if crit r  for a high risk of bias were met (plausible bias that 
seri u ly weaken  c nfide c in the res lts). If the ri k of bi  was unk own, it was consid red 
“unc e r” (pl ib ias th t ai es s me d u t about th r lts). Full etail  are given in Table 1 
and Figure 1. 
Table 1. Risk of bi  gra : r view of uth rs’ judge e t  abou  e ch risk of bias item presented s 
perc nt ges acro  ll included st ies.  i dicates low risk of bias,  i dicates u known risk 
of bias, nd  indicates high risk of bias. 
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The mean (M), standar  d vi ion (SD), and sample siz dat  w re extract d by on  author from 
the tabl s of l of t  inclu ed pap s (DMJ). When v n ces ary, w  contac ed the authors to obtain 
he data. When i  was i possible, m an nd SD were extrapola ed rom the figures. Any 
di agr ement was re olv d by consensus (J A nd DMJ) or hird-par y adjudicat on (JCG). 
2.4. Qu lity Ass ssment f the Expe i nts 
Metho o ogical quality a d risk of bias re sesse  by t o auth r  independ ly (JMA  
DMJ), and isagr ements w e r solv  by hird- arty valua i  (JCG), i  ccor a c  with  
chrane Collabor t on Gui eli es [24]. The items on the li  w r  divi d i to diff r nt mains: 
random s quenc  gen r ti  (s l ction bi s), all t on c nc lm nt (sel ctio bias), blindin  f
participants d per o n l (performance bias), bli ding of outc e ass ssment (detection bia ),
inc mpl te utcom d ta ( ttri i n ), s lect v  o (r p ti g bias), and other types of ias. 
T ey w e ch racter zed a  “ ” if crit ri for a low risk of bias were met (pla sible bias unlikely to 
s riou ly alter t e r sults) or “hig ” if criteria for a igh risk of b as were me (plausible bias that 
s riously weak s confidence in th r ult ). If the risk f bia as unknown, it as co sid red
“un l ar” (plausi le bia  ha  r i e  s m d b s b ut th r s l s). Full det i are giv  in Tabl 1 
and Figure 1. 
Table 1. Risk of bias graph: r v ew of authors’ judge nts bout each risk of bia  item presented s 
perce t ges across all in lude  tu ies.  ndicates low risk of bias,  indicates u known r sk
of bias, and  ind cates h gh risk of bias. 
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The m n (M), s ndard d viati n (SD), and sample siz  data w re extracted by one author from 
th  t bles of all of th included pa s (DMJ). W enever necessary, we contacted the authors to obtain 
h data. Wh n it was im ssibl , m an and SD were extrapolated from the figures. Any 
di agr eme t s resol ed by consensus (JMA and DMJ) or thi d-party djudication (JCG). 
2.4. Q lity A ment f th  Ex rim  
M thodol gic l quality and risk of bia  r  ass ss d by two authors independently (JMA nd 
DM ), nd isag e ments we e r s lv d by ird- art v luation (JCG), in accordance with the 
C ch n C ll b r ti n Guid li s [24]. Th  t m  o  th  l st w r d vi ed into dif erent domains: 
ra dom s qu nc g ner ti ( e ction bias), a l cation concealment (selection bia ), blinding of 
particip ts  p r o l (perf rmanc bi ), bli ding of utcom  ass ssment (detection bias), 
compl te o tc m  d t  ( tt i io bias), l cti e reporting (report g bias), and other types of ias. 
They were ch ract ized s “low” if criteria for a low ris  of bias were met (plausible bias unlikely to 
s ou ly lter t e results) or “hig ” if criteri  for a high risk of bias were met (plausible bias that 
se io ly eaken c fidenc i  e r ults). If the ri k of bia  as unknown, it was considered 
“unc ear” (pl ible bi s h  is  s me d ts about the results). Full detai s are given in Table 1 
and Figure 1. 
Ta le 1. Risk f bia  graph: review of u h rs’ judgement  bout each risk of bias item presented as 
perce tag a r ss ll included studies.  i dicates low risk of bias,  ndicates u known r sk 
of bias, and  ndi at s high risk of ias. 
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The mean (M), stand rd deviation (SD), and sample siz  data wer  ext acted y on  author from 
the tables of all of the included papers (D J). Whenever ece sary, we contacted th  author  o obtain 
the data. When it was i possible, ea  and SD we  ext apola ed from the figures. A y 
disagreement was resolved by c nsensus (JMA and DMJ) or third-party adjudication (JCG). 
2.4. Quality Assessment of th  Expe ments 
Methodologic l qu lity and risk of bias wer  ssessed by two auth r  i depe ently (JMA  
DMJ), and disagre ments were res lv  by third-party evaluation (JCG), i  accorda ce with the 
Cochrane Collaboration Guid li es [24]. The ite s on t e list we e divi ed int  differe t domai : 
random sequence g neration ( lecti n bias), alloc tion c c alment (selection bi s), blinding of 
participant  and personn l (p rf rmance bias), bli ding of outcome assessment (detectio  bi ), 
incomplete outcome dat  ( ttr t on bias), s lectiv po ting (r porting ias), nd o h r typ s  ia . 
They were charact rized as “low” if crit ria for a low risk of bias were met (plausible bias unlikely to 
seriously alter th  results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the results). If the risk of bias was unknown, it was considered 
“unclear” (plausibl  bias hat r is s me u ts bou t r ul s). F ll det ils re g ven in Table 1 
and Figure 1. 
Table 1. Risk of bia  gr ph: r vi w of authors’ ju gements about ea h risk of bias ite  resent d as 
percent ges cross all included tudies.  indi ates l w risk f i s,  indicates unknown risk 
of bias, and  indicates high risk of bias. 
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The me  (M), standard deviation (SD), and sample siz  data were extracted by o  author from 
the tables of all of the included papers (DMJ). Whenever ec sary, we cont cted t  authors to obtain 
the data. When it w s impossible, mean and SD we  extrap lated from the figu s. A y 
disagreem nt was resolv d by co sensus (JMA and DMJ) or hir -party adjudic tion (JCG). 
2.4. Quality Asses me t of th  Expe m nts 
Methodologic l qu lity and sk of bia  w re assessed y two authors i dep d ntly (JMA a d 
DMJ), and disagre ments were r solve  by hird- ar y evaluati  (JCG), i  acc r anc  with he 
Cochrane C ll boratio  Guid lines [24]. The ite s on th list w re divi d into iffer t omain : 
rand m sequ nce ge ration ( lecti n bias), all cation c ncea ment (s lection bias), blinding of
participant  a d pers n l (p rformance bias), bl ding of outcome as ssme t (d tecti  bi ), 
incomplet ou com dat ( ttrit on bias), s l ctive r p ting (r p r ing ias), nd th r typ s s. 
They were char cterize as “low” if criteria for a low risk of bias were met (pl usib e bias unlikely to 
seriously ter the esults) or “h gh” i  criter a for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the results). If the ri k of bias was unknown, it was considered 
“unclear” (pl usi l bi s th t rai s s me ubts bo t e esults). F ll d t ils a e given in Ta le 1
and Figure 1. 
Table 1. Risk of bias graph: r vi w f authors’ judgem ts bout each i  f i s item rese t d as 
per ent es acr s  ll included studies.  indi ate  l w risk of bias,  i dicates un nown risk 
of bias, and  indicates high risk of bias. 
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The m an (M), stand r  deviation (SD), nd s mple siz d a w re xt acted by one author from 
the tables of l  of the included papers (DMJ). Wh never nec a y, w c ntacte  the authors to obtain 
the data. When it w s impossible, ean nd SD were xtr ol t  from the figures. Any 
disagreement was re lved by c ns nsus (J A and DMJ) r third-pa ty adjudicatio  (JC ). 
2.4. Qu lity Assessm t f th  Experim n s 
Metho ologic l quality d ri k of ias were assesse  y two author  i depend ntly (JMA nd 
DMJ), and disagre m nts w e resolved by third-p rty eval atio (JCG), i  accordance with the 
chrane Collaboration Guideli s [24]. The it  on the l s  wer  divided into differe t domains: 
r dom s quen  g n rati  (s l cti  bias), alloc tion c cealment (s cti n s), linding of 
pa ticipant   perso n l (p rforma ce b a ), blinding f utco  assessment (detection bias), 
incomplet  outcom d ta ( ttrition b as), sel ctive r p ting (r p i g bias), nd oth typ s of ia . 
Th y were chara terized as “lo ” if criteri  for a low risk of b as were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weake s co fid nce in the results). If the risk of b as was u known, it was consider d 
“unclea ” (plau l  bi s hat r ise  s me ubt b u  e re ult ). Full det ls are giv n i Table 1 
and Figure 1. 
T bl 1. Risk f bias g aph: evi w f authors’ j ge ts about each risk of bias i m resented as 
percenta es acr s all included studies. indi tes l w risk of ias,  indicates u known risk 
of bias, and  indicates high risk of bias. 
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The mean (M), tan ard devi ti n (SD), and sample siz da a w re extracted by one author from 
the abl s of al f the n lud d papers (DMJ). Whenever nece sary, we contac d he authors to obtain 
the data. Wh n t was i possibl , mean and SD ere xtrapolat d from th figures. Any 
disagreement was res lved by consensus (J A d DMJ) or hir -p rty ju icat  (JCG). 
2.4. Quality A essme t of the Exper me
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incom lete ut om  data (attrition a ), s l ct v  p rting ( po t g i ), d other typ s of ia .
They were characterized as “l ” if criteria for  low risk of bias were met (plausible bias unlikely to 
ser ously alter the results) or “high” if crit ria for a high risk of bias were met (plausible bias that 
seriously weake s co fid nce in the res lt ). If the risk of bias was unknown, it was c nsidered 
“u c e ” (pl usibl bia  hat i e  s m  u ts ab u  t e results). Full details a e iv n in Table 1 
and Figure 1. 
Table 1. Ri k of bias gr ph: vi w of uth rs’ judge t  bou  ch risk of bias i m rese ted as 
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of bias, nd  ndicates high risk of ias. 
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The mean (M), standar  devi ti n (SD), a d sample size dat  wer  extracted by on  uth r from 
the tables of a l of the inclu ed papers (DMJ). Wh nev necessa y, w  cont ct d the authors t  obtain 
the data. When i  was i pos ible, ean a d SD re extrapola ed rom the fi ures. Any 
disagr ement was re olv d by consensus (J A and DMJ) or third-par y adjudicat on (JCG).
2.4. Quality Ass ssme t f th  Exper me  
Method ogic l qualit  nd r sk f bi s were assessed by t o auth r  ind p ndently (JMA nd
DMJ), and disagr ments w r  r solve  by third-p rty valua ion (JCG), i  ccord ce with the 
ochran  Coll orat on Guid lin s [24]. The it ms on he list w r  divided i o iffere t om i : 
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participants d perso n l (performance bias), blinding of outco e assessme t (det ction b as), 
incompl te utc m  dat ( ttr ion bi s), elective (rep rtin  bi s), d th r typ s of ias. 
T ey w e charact rized as “low” if criteria o  a low risk of bias were met (pla sible bias unlikely to 
ser ously alter the r sul s) or “hig ” if criteria fo  a igh isk of bia  were met (plausible bia  that 
s riously weak s confiden e in the results). If the risk of bia as unknown, it as co sidered
“uncl ar” (plausible bia t t r e  om  o b b e r ul s) Full detail  ar given in Table 1
and Figure 1. 
Table 1. Risk f bias gr ph: rev ew of authors’ judgeme ts ab ut ea h risk of bias item re e ted s 
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of bias, and  ind cates h gh risk of bias. 
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disagree nt as resolv d by cons nsu  (J A nd D J) or hir -pa y a judication (JCG). 
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etho ogical quality and r sk f ia  ere assess  by t  uthors ind p ndently (J A nd 
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rando  s q nc  ge erati  (s lectio  bias), a l ation c nc ent (se ctio i s), blindin of
participants personn l (perfor a ce bias), blinding f outco e ass ss ent ( etection bias),
inco l t u co data ( tr ion b as), s l ctiv o (repo ting bia ), d ther typ s of ias. 
T ey e char cterized s “ ” if criteri for a lo risk of bias ere et (pl sib e bi s un ikely to 
seriously alter the esults) o  “h gh” i  criter a or a h gh risk of b as ere e (plausible bi s that
s riously eak s confidence in the r sult ). If the risk of bias as unkno n, it as considered 
“un l r” (pl usib e bia  h t r i e  s  d bts ab t the r s l s). Fu l det ils are giv  in Tabl  1 
and Figure 1. 
Tabl  1. Risk of bi s graph: r view of auth rs’ jud ts about e ch risk of bias tem resented as 
per e t ges a r s l in luded stu ies.  di ates l w risk of bias,  i dicates u nown ris  
of bias, and  ind cates h gh risk of bias. 
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the tables of all of the included papers (DMJ). Whenever necessary, we contacted the authors to obtain 
the ta. Whe  it w s impossi le, mean and SD wer  extrapolate  from the figures. Any 
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2.4. Quality Ass ssment of e Experimen s 
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parti i ants d rso n l (perform nce bi s), blindi g of outcome assessment (detection bias), 
incom let  utcom  d ta (attritio  bias), selectiv  reporting (reporting bias), and other types of ias. 
They re characterized as “low” if criteria for a low risk of bias were met (plausible bias unlikely to 
seriously alter the res lts) or “ igh” if criteria for a igh risk of bias were met (plausible bias that 
seriously eake s confi ence in the results). If the risk of bias was unknown, it was considered 
“ cl ar” (pl usible ia that r i es s me d ubts about the results). Full details are given in Table 1 
and Figure 1. 
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T  m an (M), sta ar  d viati  (SD), nd sample s ze ata w re xtracted by one a thor from 
the tables of all of th  included papers (DMJ). Whe ever ecessary, we contact d t e auth rs t  obtain 
t e data. W it w s impossi l , an d SD w re extrapolated f om the figures. Any 
disagre me t was res l   co s nsus (JMA n  DMJ) or third-p rty adjudic tion (JCG). 
2.4. Quality Assessmen  of the Exp rimen  
M od log c l qu l y nd i  ere sse s d by tw  authors in pend tly (JMA and 
DMJ), nd dis gree e ts wer ved by th rd-p rty valuati  (JCG), n accorda c  with the 
Cochr  C la ora n G idelines [24]. The items on th  t er  div e into different domai s:
random seq e ce gener tion (selection bia ), allocation c cealme t (selectio  bias), blindi g of 
participa ts and p rsonn l (p rformance bi ), lindi g of utcome ssessment (d t ction bias), 
i c mplete utcom  data ( ttr tion ias), selectiv  reporting (reporting bias), nd other types f bi s. 
They er  characterized as “l ” if criteri  f r  lo  risk of bias w r  m t (plausible bias unlikely to 
seriously alter the results) or “ igh” if criteri  f r a high risk of bias were met (pl usible bi s that 
seriously weake s co fide ce in the results). If the risk of bias was unknow , it was considere  
“uncl ar” ( au ible ia  at raise  me o bts about th  ults). Full d tail  r  give  in Table 1 
and Figure 1. 
Table 1. Risk of bias grap : review of u h rs’ judgements about each risk of bias item pres nted as 
perce tage  across all i cluded stu ies.  indicates low risk f ias,  indicates u known risk 
of bi s, and  indi ate  high risk of bias. 
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The mea  (M), sta d rd eviation (SD), and sampl  size data w re ex ract  by o e aut r from 
the tabl s of all f the i clud d pap rs (DMJ). Whe ev r necessary, we c nt cted t e authors to obtai  
the dat . Whe  it w s im ossi l , m a  and SD were extrapolate  fro  the figu . A y 
disagree e t was r s lved by c sensus (JMA d DMJ) or third-p rty a judic ti n (JCG). 
2.4. Quality Assessme t f the Ex im nts 
Method logic l quality and risk of ia  wer  a sessed y wo a thors ind pe ently (JMA a d 
DMJ), and isagre ments wer  esol ed y third-p rty evalu tio  (JCG), i  accor a ce with the 
Cochr ne Collaboratio  Guid li es [24]. The ite s on t  li t wer  divi d int  diff r nt omain : 
random seq enc  ge rati n ( lecti n bias), a location c nc alment (selection i s), blinding of 
participant  n  personn l (p rf rmance bias), bli ding of outcome assess ent ( etectio  bi ), 
i com let  outcom d ta ( ttrit on bi s), l ctiv r p ti g (r por ng ias), nd th r typ s. 
They w re characterize  as “low” if crit ria for a low risk of bias were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the results). If the ri k of bias was unknown, it was considered 
“uncle r” (pl usi  bi s that rais me ubts abou the r ults). F ll et ils are given in Table 1
and Figure 1. 
Table 1. Risk of bia  graph: r vi w of authors’ ju g m nts about e ch i  f i s item present  as 
percent ges acros  ll inclu e  studies.  indic te  low risk of bias,  i icates u know  risk
of bias, and  indicates high risk of bia . 
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The mean (M), sta dard evi tion (SD), a d sample siz a  w re extracted by one auth r from 
the tables of al  f the i clud d pap rs (DMJ). Wh ever necessary, we co t cte  the auth rs to obtai  
the dat . Whe  it w s i ossi l , m a  a d SD w r  xtrapol te  from the figures. Any 
dis gree ent was r s lved by c sensus (J A nd DMJ) or third-p ty adjudication (JC ). 
2.4. Quality Assessm nt  h  Expe im nts 
Methodologic l quality and risk of bias were asses ed y two auth r  i depend ntly (JMA nd 
DMJ), and disagre me ts w e res lve  by third-party evaluatio (JCG), in acc rda c  with the 
chrane Collaboration Guidelin s [24]. Th  it  on the l st wer  divided i t  differe t domains: 
random s quenc  g n rati  (selecti  bias), alloc tion once l nt (sel ction b s), linding of 
pa ticipant  d p rsonn l (p rformanc  b as), blindi g of outc  assessment ( et ction bias), 
i complet  outcom ta ( ttrition b as), se ctiv r p ting (r po i g bia ), d o h typ  f ias. 
They were characterized as “low” if criteria for a low risk of bias were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weake s co fid nce in the results). If the ri k of bias was unknown, it was considered 
“unclea ” (plau i le bi s hat r se  s e oub ab u t e r lts). Full et ls a e g v n i Table 1 
and Figure 1. 
T bl  1. Risk of bias graph: r view of author ’ judge ts ab ut each ris  f i s i m r ented as 
percent ges cross all include  tudies.  indi t s l w risk of bias,  i dic tes u known risk 
of bias, and  indicates high risk of ia . 
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The mea  (M), sta dard dev ati n (SD), and sampl iz a a w re extr cted by one auth r from 
the t bles of al  of the i cluded p p rs (DMJ). Wh v r necessary, we co t c ed he auth rs to obtain 
the dat . When it was i ossible, m n and SD wer xtr polat d from th figures. Any 
disagreement was re lved by c se sus (J A d DMJ) or hird-p rty djudicati n (JCG). 
2.4. Qua ity A e sme t of the Expe im nts 
Metho logic l quality and ri k of i s were assess d by two authors i d pe dently (JMA nd 
DMJ), a d is gr e ts w re res l d by hir -p ty evalu tio (JCG), i  acc rd ce with the 
ch n  Collaboration Guid lines [24]. Th  it  on th  st w  divid d into diff re t domai s: 
random s q c  gen rati n (selection bias), llocation conc l nt (selection b as), blinding of 
participant   p rsonn l (performanc  b as), bli ding of outc  assessment ( t ction bias), 
incomplete utcom  d ta (attr ti n as), l t v port ng (r po ti g bias), d other typ s of ia . 
They were characterized as “l ” if criteria for a low risk of bias were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weake s co fid nce in the result ). If the ri k of bias was unknown, it was considered 
“u cle ” (pl u ible ia hat r i e  s m  do bts ab u  the result ). Full details a e iv n in Table 1 
and Fig re 1. 
T ble 1. Risk of b as graph: r vi w of auth rs’ judgem nts b ut ch r sk of bias i m resented as 
p r ent ges a ross ll i clud d stu ie .  ndi ates l w risk of bias,  i di ates u known risk 
of bias, and  ndicates high risk of ias. 
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ser ously alter the esults) or “h gh” i  crit r a for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the res lts). If the ri k of b as was u known, it was considered 
“ nc e r” (pl u ib ias th t i s s me d u a o t he r lts). Full etail  are given in Table 1 
and Fig re 1. 
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seriously alter the r sults) o  “hig ” if criteria or a gh risk of bias ere et (plausible bi s that
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and Figure 1. 
Table 1. Risk of bi s graph: r v ew of a thors’ judge en s ab ut each risk of bias tem resented s 
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the t bles of all f the included papers (DMJ). Whenever necessary, we contacted the authors to obtain 
th  at . Wh n it was impossible, mean and SD were extrapolated from the figures. Any 
isagreeme t s resolved by cons nsus (JMA and DMJ) or third-party adjudication (JCG). 
2.4. Q ality Asse sment of e Expe imen s 
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Coc ran C ll b ati n Gui elin s [24]. Th  items on th  l st wer  divided into different domains: 
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p rticipants nd rso n l (perf rma ce bi s), blinding of outcome assessment (detection bias), 
i co l te tc  ta (attriti n bia ), lective reporting (reporting bias), and other types of ias. 
They re characterized as “lo ” if criteria for a low risk of bias were met (plausible bias unlikely to 
seriously lter the res lts) or “high” if criteria for a high risk of bias were met (plausible bias that 
seri u ly eake s confi ence in the results). If the risk of bias was unknown, it was considered 
“u clear” (pl usible bia  that r se  s me doubts about the results). Full details are given in Table 1 
an  Figure 1. 
Table 1. Risk of b s graph: review of authors’ judgements about each risk of bias item presented as 
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The me n (M), sta rd dev ti n (SD), d sample siz  data were extracted by one auth r from 
the tables of all of the i cluded pap rs (DMJ). Whenever neces ary, we contacted the uthors to btai  
the dat . When it was i ossible,  and SD were extrapol te  from the figures. Any 
disagreement was r solved by c sensus (JMA an  DMJ) or third-par y adjudic tion (JCG . 
2.4. Quality Assessment of th  Exper ments 
Methodological quality d i k of bia  re as essed by tw  auth s i dep dently (JMA  
DMJ), and disagr ements w r  es lved y third-p rty evalu ti n (JCG), i  acc rd ce with the 
Cochrane Coll boration Guid li es [24]. Th  items on t  list e  divi d i to different domains: 
r nd m sequ nc  generati n (s l ction bias), all cation conc alment (s lection i s), blinding of 
participants n  pers n l (p rformance bia ), bli di g of outcom  assess ent (detecti  bias), 
incomplet  outcom  dat  ( ttri on bi s), l ctiv p ting (r porting ia ), and o h r type  ia . 
They were characterized as “low” if criteria for a low risk of bias were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the results). If the ri k of bias wa  unk own, it was considered 
“unclear” (pl us ble bia hat r is s m  ts abou th e ul s). F ll detail re given in Table 1
and Figure 1. 
Table 1. Risk of bias gr ph: revi w of authors’ j gements about ea h risk of bias item present d as 
percentages across all included studies. indicates low risk of bias, in icat s u know  risk 
of bias, and  indicates high risk of bias. 
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the tabl s of all f the includ d pap rs (DMJ). Whe ev r nec s ary, we c nt cted t e author to obtai  
the data. Whe  it w s impossi l , m  and SD were extrap l te  from the figure . Any 
disagree e t was res lved b  c sensus (JMA  DMJ) or hir -p rty djudication (JCG). 
2.4. Quality Assessment f th  Expe ments 
Method logic l quality n  risk of ia  wer  asse d by two author  in pen ently (JMA a d 
DMJ), and is gre ments wer es l e  y hird-p r y evalu tion (JCG), in ccorda c  with he 
Co r ne C llaborati  Guidelin s [24]. The ite s on th list wer  divi d int iff r t dom in : 
random seq nc  ge erati n ( electi n bi s), all cati n c nc a ment (selection i s), blinding of
participa t   pe sonn l (p rformance i s), blinding of o tcome as ss ent ( t ction bi ), 
i complet ou com dat ( ttrit on bi s), el ctiv r p ti g (r por ing bias), nd th r typ s. 
They w re char cterized as “low” if crit ria for a low risk of bias were met (pl usib e bias unlikely to 
seriously alter the esults) or “h gh” i  cr ter a for a high risk of bias wer  met (plausible bias that 
seriously weakens confidence in the re ults). If the ri k of bias was unknown, it w s c nsidered 
“uncle r” (pl u i bi s hat rai s me u ts a o t the r s lts). Ful  details are given in Ta le 1
and Figure 1. 
Table 1. Risk of bia  graph: r vi w of uthors’ judgements about e ch i  f i s item pr sent d as 
per ent ges acros  ll include  studies. indic te  low risk of bias, i icates u now  risk 
of bias, and  indicates high risk of bias. 
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The m an (M), sta d r  evi ti n (SD), d sample siz da a w re ext acted by one auth r from 
the tables of l  f the i clud d pa rs (DMJ). Wh ever necessary, we co t cte  the uth rs to obtai  
the dat . Whe  it w s im ossibl , an d SD w re xtra lat  from the figures. Any 
dis greement was r lved by c sensus (J A nd DMJ) or third-party adjudication (JCG). 
2.4. Quality Assessm nt f th  Expe im nts 
M tho ologic l qual ty and ri k of ias w re asse  by wo auth r  i depende tly (JMA a d 
DMJ), a d disagre me ts w e s lved y th rd-party evaluatio (JCG), in cc r c  with the 
chr e Collabor ti n Guidelin  [24]. Th  it  on the l st wer  divid d i t  differe t domains: 
a dom s quen e g neratio  ( election bias), alloc tion c ce l nt (se cti n b s), linding of 
pa ticipa t  a d p sonn l (p rformanc  ), blindi g of utc  ass ssment ( et ction bias), 
incomplet  outcom d t  ( ttrition b as), se ctiv r p ting (r p r i g ia ), d othe typ  f bia . 
Th y were chara terized as “lo ” if criteri  for a low risk of b as were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias wer  met (plausible bias that 
seriously weake s co fid nce in the results). If the ri k of b as was u known, it wa  cons der d 
“u clea ” (plau i le bi s hat is s me d u b e r lts). Full deta ls a  g v n i Table 1 
and Figure 1. 
T bl 1. Risk f bia  g aph: r view of auth rs’ j ge nts about ach ris  f i s i m resented as 
percent ges acro s all include  studies. indi tes l w risk of bias,  i dic t s u know  risk 
of bias, and  indicates high risk of ias. 
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T e mea (M), sta dard deviation (SD), and sampl  siz a a w re extracted by one auth r from 
the tables of al of the i clud d pap rs (DMJ). Wh ver nece sary, we cont c d the auth rs to obtain 
the dat . When it was im ossible, m n and SD wer xtr p lated from th  figures. Any 
disagreement was r s lved by c sensus (J A and DMJ) or hird-p rty adjudicati n (JCG). 
2.4. Quality As essme t of the Expe im ts
Metho l gic l quality an  risk of i s w r  assess d by t o uth rs ind pende tly (JMA and 
DMJ), a d is gr ments w re s l d y thir -p ty v lu io (JCG), i  acco d ce with the 
ch n  Collabor ti n Guid lin  [24]. Th  it m on th l st w  divid d into diff re t dom ins:
andom seq nce gen rati  ( el ctio  bias), llocat on conc lment (s lec ion b as), blinding of 
a ticip t  a  personnel (performance b a ), bli di g of utc assess t ( et ction bias), 
incomplete ut ome data (attr i n b a ), s l t p rt ng ( p t g ia ), nd oth r typ s of bia . 
They were characterized as “l ” if criteria for  low risk of bias were met (plausible bias unlikely to 
ser ously alter the results) or “high” if crit ri  for a high risk of bias were met (plausible bias that 
seriously weake s co fid nce in the re lt ). If the ri k of ias was unknown, it was c nsidered 
“u cle r” (pl usible bia hat i s m  doubt abou  t e re lt ). F ll etails are giv n in T ble 1 
and Fig re 1. 
Table 1. Risk of bi s gr ph: r vi w of auth rs’ judge nt  b ut ch risk of bias i m resented as 
p r nt ges a ross all i clud d studie .  ndi ates l w risk of bias,  dicates unknown risk 
of bias, nd  ndicates high risk of bias. 
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T e m  (M), ta ar  eviation (SD), an  sampl  size data were extract d by one author from 
the table  f al  f the i clud d papers (DMJ). Whe ever necessary, we ontacted the authors to obtain 
 t . Wh n it s mp i l , n a  SD wer  extrapolate  from the figures. Any 
d s g me w s re lv  by co n us (JMA a d DMJ) r third-p rty adjudication (JCG). 
2.4. Qu lity A e m nt of e Experim t  
Met od l gic l qual ty d i  ere a sessed y two authors independently (JMA and 
DMJ),  isagre men s er res lve  y th r -party evaluati  (JCG), in ccordance with the 
Cochr  C l ab ra o  Gui lin [24]. Th t s o  th  l st were divi ed into different domains: 
rand  sequence ge eration (selecti n bias), allocation concealme t (selection bias), blinding of 
participants nd p rs nnel (performance bias), blindi g of outcome assessment (detection bias), 
inc mplet  tc e ata (attrition i s), el ct v  r p rting (reporti  bias), nd other types of bias. 
They ere characterize  s “lo ” if criteria for a low risk of bias were m t (plausible bias unlikely to 
seriously alter the results) or “ igh” if criteria for a high risk of bias were met (plausible bias that 
seriously weakens confide ce in the results). If th  risk of bias was unknown, it was considered 
“uncl r” ( lau ible bia  h t a ses s me oubts ut he sults). Full details are given in Table 1 
and Figure 1. 
Table 1. Ri k of bias gr ph: revi w of authors’ judgements a out each risk of bias item presented as 
percent g  ross ll includ d tu ie .  indicates low ri k of bias,  indicates unknown risk 
of bias, a d i dicates h gh risk of bias. 
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The ean ( ), st d r devi ti n (SD), an  sa ple size at  re xtr cted by on  auth r fro  
the t bl  of a l of th  i cluded p p rs (D J). henev r ess ry, e contac ed h  uth rs t  ob ai  
the dat . hen it s i ossible, a  nd SD er extra la ed r  th  figure . Any 
disagre ent as r s lv d by c se us (J A nd D J) or hird-pa ty judication (JCG). 
2.4. Qu lity A se sment f the Expe i ents 
tho o gic l quality and risk f bias ere assess  by t o thors independently (J A nd 
D J), a d disagr ents re r olv d y thir -party evalua i  (JCG), in accor a ce ith th
chr ne Co l borat n Guideli s [24]. The ite s n th  list r  divi d i o i f re t ains: 
rando  s quenc  generati  (selection bias), a lo ation c nc al ent (se ctio bias), blindin of
participants d personn l (perfor ance bias), bli ding of outc me ass ss e t (detection bias),
inco pl te utco d ta ( trition ), s l ctive (rep ti g bias), d ther typ s f i . 
T ey e characterized s “ ” if criteri for a lo risk of bias ere et (pla sible bi s un ikely to 
seriously alter the results) o  “high” if criteria or a h gh risk of b as er e (plausible bi s that
s riously eak s confide ce in the r ult ). If the ri k of bias as unkno n, it a  con idered 
“un ear” (p ausible bia h t r i e  s  d u ts bo t the r s l ). Fu l det il  are giv  in Tabl  1 
and Figure 1. 
Table 1. Risk of bias graph: r view of uthors’ judge nts ab ut each risk of ia  tem r sente s 
perce t ges acro s a l in lude  stu ies.  di ates l w risk of bias,  indicates u known is
of bias, and  ind cates h gh risk of bias. 
 
Ra
nd
om
 se
qu
en
ce 
ge
ne
rat
ion
 (s
ele
cti
on
 bi
as)
 
Al
loc
ati
on
 co
nc
eal
me
nt 
(se
lec
tio
n b
ias
) 
Bl
ind
ing
 of
 pa
rti
cip
an
ts 
an
d p
ers
on
ne
l 
(pe
rfo
rm
an
ce 
bia
s) 
Bl
ind
ing
 of
 ou
tco
me
 
ass
ess
me
nt 
(de
tec
tio
n 
bia
s) 
Inc
om
ple
te 
ou
tco
me
 da
ta 
(at
trit
ion
 bi
as)
 
Se
lec
tiv
e r
ep
ort
ing
 
(re
po
rtin
g b
ias
) 
Ot
he
r b
ias
 
ujika et al. 2 00 [ 7]        
emben t l. 01 6]        
Cox et al. 2 02 [21]
Biwer et al. 20 3 [15]
Ostojic 2004 [ 8]        
Claudino et al. 2014 [20]        
i liams et al. 2014 [16]        
Ramírez-Campi o et l. 2015 
[19]        
Yáñez-Silva et al. 2017 [7]        
 
  
Nutr ent  2019, 11, x FOR PEER REVIEW 4 of 17 
The m  (M), sta ard deviatio  (SD), an  s mpl  size data were extracted by one auth r from 
the t ble  f all of th i luded pap s (DMJ). Whenever n essary, we contacted the authors to obtain 
h  dat . Wh it was im ssibl ,  and SD w r  extrapolated from the figures. Any 
i agre m  as r s lv by c sensus (JMA a d DMJ) or third-party adjudication (JCG). 
2.4. Q lity A me t f the Ex rim
M th dol gic l quali y nd risk of bia  r  assess d b two authors independently (JMA d 
DMJ), and i gr e ent  w r  olved y ird- rty ev luat on (JCG), in accordance with the 
Cochr n  C llaborati n Guide nes [24]. Th  t m   th  l w r  divided into dif erent domains: 
r ndom s quenc  g nerati n ( election bia ), a l catio  concealment (selection bia ), blinding of 
p rticip nts  perso l (perf rm nc  bias), bli ding of outcome assess ent (detection bias), 
ncompl outc m t (a rit b s), l ctiv rep rting (rep rti g bias), and other types of ias. 
They were ch ract ized s “l w” if criteria for a low ris  of bias w re met (plausible bias unlikely to 
seriously lter t e results) or “high” if criteri  for a h gh risk of bias were met (plausible bias that 
s riou ly weaken  c fidence in he results). If th  ri k of bias was unknown, it was considered 
“unc ar” (pl u i le tha  rai s some d s about the results). Full details are given in Table 1
and Figure 1. 
Ta l  1. Risk f bia  g aph: review of u h rs’ judg ment  about e ch risk of bias item presented as 
perce ag a r ss ll included stu e .  i i low isk of bias,  indicates u know  r sk 
of bias, and  ndicat s high risk of ias. 
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The mean (M), stand rd devi ti n (SD), and sample siz  data were extracte  by o e author from 
the tables of all f the i cluded papers (DMJ). Whe ver neces ary, w  contacte  the uthors o btai  
the data. When it was i possible, e  and SD were xtrapolate  fro  the figu es. Any 
disagreeme t was resolved b  c nsensus (JMA n  DMJ) or third-party a judication (JCG). 
2.4. Quality Assessment o  the Ex iments 
Methodologic l quality and risk of bias were assessed by two aut rs i depe ently (JMA  
DMJ), and disagr ment  w r  r lv  by thir -party v l ation (JCG), i  cc rd ce with th  
Cochrane Collaboration Guid li es [24]. Th  t s on t e l st w  divi ed int  if ere t domai : 
random sequence g nerati n ( lecti n bias), a location c nc alment (selection bia ), blinding of 
participant  nd personn l (p rf rmanc  bias), bli ding of outcome assessment (detectio  bi ), 
incomplete outcom  d t  ( ttr ion bi s), elective po t g (reporting as , and o h r typ s  i . 
They were characterized s “low” if crit ria for a low risk of ias were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias were met (plausible bias that 
seriously weakens confidence in the re ults). If the risk f bias wa  unk ow , it w s c nsid red 
“unclear” (pl usibl  bia hat r s m  ts abou th r s l s). F ll d tails re v n in Table 1 
and Figure 1. 
Table 1. Risk of bias gr ph: r vi w of authors’ j gements about each risk of bi s item r sent d as 
percent ges across all included studies.  indi ates l w risk f i s,  in icat s u k own r sk 
of bias, and  indicates high risk of bias. 
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The me  (M), stand rd deviatio  (SD), and sample size data w re extracte  by one author from 
t e tables of all f the i clud d pap rs (DMJ). Whe ev r nec ssary, we c nt cted t e authors to obtai  
the data. Whe  it w s impossi l , m a  and SD were extrap late  fro  the figu . Any 
disagreem t was res lved b  c sensus (JMA n  DMJ) r hir -par y a judic ti n (JCG). 
2.4. Quality A se s e t f th  Expe ments
Method logic l qu li y  isk of ia  we e assessed y two author  i d p nd ntly (JMA and 
DMJ), and isagre ent  wer r ol e  by hir -p r y val ti  (JCG), i  accor anc  with he
Cochr ne C ll boratio  Guid li es [24]. The ite s on t list w r  divi d into iff r  doma n : 
rand m seq nc  ge rati n ( lecti n bi s), all cation c nc a ment (s lecti n i s), blinding of
participant   pers n l (p rformance bias), bli ding of outcome as ssme t ( tecti  bi ), 
inco let ou com d t ( ttrit on bi s), l ctiv r p t g (r por ng ias), nd th r typ s. 
They were characterize as “low” if criteria for a low risk f bias were m t (pl usib e bias unlikely to 
seri usly alter the esults) or “h gh” i  cr ter a for a high risk of bi s wer  et (plausible bias that 
seriously weakens confidence in the r ults). If the ri k f bias was u known, it w s c nsidered 
“u cle r” (pl usi b hat rai s e ubts abo the e lts). F ll d t ils a e giv n in Ta le 1 
and Figure 1. 
Table 1. Risk of bias graph: r vi w of authors’ judgem nts about e ch i  f i s item r se t d as 
per ent ges acros  ll include  studies.  indi te  l w risk of bias,  i icates u nown risk 
of bias, and  indicates high risk f bias. 
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The m an (M), sta d r  eviation (SD), nd sample siz da a w re ext acted by o e auth r from 
the tables of l  f the i clud d pa rs (DMJ). Wh ever necessary, we cont cte  the authors to obtain 
the dat . Whe  it w s i os i l , ean nd SD were xtra l t  from the figures. Any 
isagree ent was r lv d by c sensus (J A n  DMJ) or third-p ty adjud cation (JC ). 
2.4. Quality Assess t f th  Expe im nts
Metho ologic l quality d ri k o ias were a esse  y tw  auth r  i depend tly (JMA nd 
DMJ), nd di agre m ts w r olve  by thir -party eval atio (JCG), i  ac ord nc  with the 
chran  Collabor tion Guidelin s [24]. The it  on the l st wer  divid d in  differe t domains: 
r dom s quen  g n rati  (sel cti n bias), alloc tion c ce l nt (se cti n s), linding of 
pa ticipant   p rso n l (p rformanc  b a ), blindi g f outc  assessme t ( et ction bias), 
incomplet  outcom t  ( ttrition b a ), s l ctiv r p ting (r po i g ias), o h typ  of ia . 
Th y were cha a t rized as “lo ” if criteri  for a low risk of b as were met (plausible bias unlikely to 
seriously alter the results) or “high” if criteria for a high risk of bias we  met (plausible bias that 
seriously weak s co fid nce in the results). If the ri k f b as wa  u known, it wa  con der d 
“u cle ” (pl u le bia  that r ises s e ubt b   r lt ). Full d t ls a  giv n i Table 1 
and Figure 1. 
T bl 1. Risk f bias g a h: r view of authors’ judgem ts about ach ris f i s i m resented as 
percent ges acro s all include  studies. indi t s l w risk of bias,  i dicates u know  risk 
of bias, and  indicates high risk f ias. 
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The mea (M), sta dard deviation (SD), and sample siz da a w re extracted by one auth r from 
the tables of al of th  i clud d pap rs (DMJ). Whenever nece sary, we co t c ed he auth rs to obtain 
the dat . When it was i oss ble, mean and SD er xtrapolat d from th figures. Any 
isagreement was r s lved by c sensus (J A d DMJ) or hird-p rty dju ication (JCG). 
2.4. Qu lity A essme t of the Exp m
Metho l gic l quality and ri k of i s wer  assess d by t o authors ind pe de tly (JMA nd 
DMJ), nd is gre t  w  r l d by t ir -p ty v l i (JCG), i  acc da ce wit the 
ch n  Collabo ation Guid lin s [24]. Th  it on th l st w  divid d int  diff re t dom i s:
andom s q nc  gen rati  (sele tio  bias), llocat on conc l nt (s lec ion b as), blinding of 
a ticip t   p r onn l (perfo manc  b a ), bli ding of utc as essm t ( t ction bias), 
incom lete ut om  d ta ( tt i n b a ), l ct v port ng ( po t g i ), d oth r typ s of ias. 
They were characterized as “l ” if criteria for  low risk f bias were met (plausible bias unlikely to 
ser ously alter th  results) or “high” if crit ri  for a high risk of i s w e met (plausible bias that 
seriously weake s co fid nc in the re lt ). If the ri k f ias was unknown, it was c nsidered 
“unc e ” (pl usibl bia  that ai es s m  u s a u  t e results). F ll d tails a e iv n in Table 1 
and Figure 1. 
T ble 1. Risk of bias gra h: r vi w of uth rs’ ju ge t  bout e ch risk of bias i m resented s 
p r nt ges a ross all i clud d stu ie .  ndi ates l w risk of bias,  dicates u k own risk 
of bias, nd  ndicates high risk of ias. 
 
Ra
nd
om
 se
qu
en
ce 
ge
ne
rat
ion
 (s
ele
cti
on
 bi
as)
 
Al
loc
ati
on
 co
nc
eal
me
nt 
(se
lec
tio
n b
ias
) 
Bl
ind
ing
 of
 pa
rti
cip
an
ts 
an
d p
ers
on
ne
l 
(pe
rfo
rm
an
ce 
bia
s) 
Bl
ind
ing
 of
 ou
tco
me
 
ass
ess
me
nt 
(de
tec
tio
n 
bia
s) 
Inc
om
ple
te 
ou
tco
me
 da
ta 
(at
trit
ion
 bi
as)
 
Se
lec
tiv
e r
ep
ort
ing
 
(re
po
rtin
g b
ias
) 
Ot
he
r b
ias
 
Mujika et al. 2 00 [ 7]        
emben t l. 01 6]        
Cox et al. 2 02 [21] 
Biwer et al. 20 3 [15] 
Ostojic 2004 [ 8]        
Claudino et al. 2014 [20]        
Williams et al. 2014 [16]        
Ramírez-Campillo et al. 2015 
[19]        
Yáñez-Silva et al. 2017 [7]        
 
  
Nutrients 2019, 11, x FOR P E  REVIEW 4 of 17 
The mean (M), sta d r  devi ti n (SD), a  sample size dat  wer  ext acted by on  auth r from 
the tables of a l of the i cluded pap rs (DMJ). Wh n v n cess y, we contact d th  auth rs t  ob ai  
the dat . When i  was i s ible, mea  d SD ere extrap la ed r m th  fi ure . Any 
disagr ement was r lv d by c sensus (J A nd DMJ) r thi d-pa ty adjudicat on (JCG). 
2.4. Quality Assessment of the Exper e  
Method ogic l qualit  nd r sk f bias were assessed by t o auth r  ind p n ently (JMA n
DMJ), and disagreements w r  r s lve  by t ir -p ty val io  (JCG), i  acc rd ce with  
ochr ne Coll borat on Gui elin s [24]. The items on he list er  divide  i o ifferent om i : 
random sequenc  gener ti  (s l ction bias), allo tion conc al ent ( lectio bias), blinding f
participants d per o n l (performance bias), blinding of outco e assessme t (det ction b as), 
i compl e tc m d t ( ttr ion i s), elect v  (r p rtin  bi s), a d th r types of i . 
T ey w e charact r zed as “low” if criteria o  a low risk of bias were met (pla sible bias unlikely to 
seriously alter the r sul s) or “hig ” if criteria fo  a igh isk of bia were met (pl us ble bi  th t 
s riously weak s confide e in th  results). If the ri k f bia as unknow , it as co sidered
“unclear” (p ausible bia t at r i e  som  o b b e r ul s). Full d tail  ar give  i Table 1
and Figure 1. 
Table 1. Risk f bias gr ph: rev ew of authors’ judgeme ts ab ut e h risk of bias item pr e ted s 
perce t ges across all in luded tu ies.  indicates low risk of bias, indi ates u known r sk 
of bias, and  ind cates h gh risk of bias. 
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The e  ( ), st dar devi tion (SD), and sa pl size dat  ere extract d by on  auth r fro  
the tabl  of l of th i cluded pap rs (D J). henever ss ry, e cont c ed he uthors to obtain
the dat . he  it as i o si le, an nd SD ere extrap la ed r  th  figur s. Any 
disagre ent as r s lv d by c sen us (J A n  D J) or hir - ty judication (JCG). 
2.4. Quality A se sme t of th  Expe im ts 
etho ogical qualit  d risk f ia  re a sess  by t o th rs ind pend ly (J A d 
D J), and isagr ents r r sol by r - arty val a i  (JCG), i  a c nc  ith th
chr ne C labor t  Gui li s [24]. The it s on t li t r  divi  i to i f re t ins: 
rando  s q nc  gen rati  (selection bias), a l ation c nc ent (se ctio i s), blindin of
participants personn l (perfor ance bias), bli ding of outco e ass ss e t ( etection bia ),
inco l t  u co d ta ( tr ion ia ), l ctiv  i  (rep ti  bia ), d other typ s of ias. 
T ey e char cterized s “ ” if criteri for a lo risk f bias ere et (pl sib e bi s un ikely to 
seriously alter the esults) o  “h gh” i  criter a or a h gh risk of b s r e (plausible bi s that
s riously eak s confidence in th r sult ). If the ri k f bias a  unkno n, it a  consid red 
“un l r” (p usib e  h t r i e  s m d bts abo t the r s l s). F l d t ils are giv  in Tabl  1 
and Figure 1. 
Table 1. Risk of bias gra h: r view of uthors’ jud em ts about e ch risk of bias tem r sented as 
per e t ges acro s a l in lude  stu ies.  di ates l w risk of bias,  i dicates u nown ris  
of bias, and  ind cates h gh risk of bias. 
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2.5. Statistical Analysis
Descriptive data of the participants’ characteristics are reported as mean ± standard deviation.
Descriptive analys s and figures of risk of bias were performed using a spreadsheet ( icrosoft Excel
2016© USA), whereas meta-analytic statistics were made with Review Manager (RevMan) version 5.3
(Copenhagen: The Nordic Cochrane Centre, The Cochran Collaboration, 2014). The standardize
mean difference (SMD), t e number of a ticip ts, and the standard error of the SMD for each study
were used to quantify changes in the perfo man e variables when comparing the ingestion of Cr vs.
a plac bo. SMDs for e ch study group were calculat d using Hedges’s g [25]. SMDs were weighted
by the inverse of variance to calculate an overall effect and its 95% confidence interval (CI). The net
treatment effect was obtained by ubtracting the SMD of the control group fr m the SMD of the
experim ntal group. Variance was calculated fro the pooled SD of change scores in both groups.
Considering that the effect of Cr on perform nce may differ acc rding to dose and other moderators
relating to participants, we d cided to a random effects odel with the DerSimonian and Laird
method [26]. The Cohen crit ia were used to interpret the magnitude of SMD (MSMD): <0.2, trivial;
0.2–0.5, small; 0.5–0.8, moderate; and >0.8, large [27].
To avoid problem using Q statistic to assess systematic differences (heterogeneity), we calculated
the I2 st tistic, which indicated the percentage of observed total variation across studies that was due to
real h terogeneity rather than chance [24]. I2 interpretation is intuitive and lies between 0% a d 100%.
A I2 val e bet een 25% and 50% represents a s all amount of inconsistency, an I2 value between
50% and 75% represents a medium amount of h terogeneity, and an I2 v lue >75% represents a large
am nt of heterogeneity [28]. A restrictive categorization of values for I2 would not be ppropriate
for all circumstances, alt ough it would tentatively accept adj ctives of low, moderate, and high to I2
values of 25%, 50%, and 75%, respectively [28–30].
3. Results
3.1. Main Search
The literature search identified a total of 101 articles related to the selected descriptors, but only
nine articles met all the inclusion criteria (see Figure 2). From these 101 articles, 19 of them were
removed because they were duplicative. From the remaining 82 articles screened, 11 papers were
removed because they were narrative or systematic reviews and another 19 did not match the search
descriptions. From the 52 full-text articles assessed for eligibility, another 43 papers were removed
because they were unrelated to the effects of Cr on soccer physical performance. The topics and
number of studies that were excluded were: 1 article about gene polymorphisms; 7 articles that
combined Cr with other supplements, such as beta-alanine and beta-hydroxy-beta-methylbutyrate
(HMB); 20 articles on the effects of Cr on different sports, such as American football and rugby;
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1 related to muscle damage; 1 analyzing biochemical markers; 10 on clinical markers; and 3 about the
self-reported prevalence of Cr consumption. Thus, the current systematic review and meta-analysis
included nine studies.
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3.2. Creatine Supplementation
The participant and intervention characteristics of the experiments included in this systematic
review are depicted in Table 2, whereas the summary of studies included is shown in Table 3. The total
sample consisted of 168 soccer players (118 males, 50 females) with an age of 20.3± 2.0 years (from 15 to
30 years, as an average for the experimental sample).
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Table 2. Participant and intervention characteristics of the studies included in the systematic review.
Cr: creatine.
Level of participants
Elite 2 studies [17,21]
Semiprofessional or amateur 7 studies [6,7,15,16,18–20]
Age group of
participants
Under-17 2 studies [7,18]
Senior 7 studies [6,15–17,19–21]
Type of Cr
administration
Based on individual’s body mass 2 studies [7,15]
Absolute dose 7 studies [6,16–21]
Dose used
30 g/day (3 doses of 10 g daily) 1 study [18]
20 g/day (4 doses of 5 g daily) 6 studies [6,16,17,19–21]
0.3 g/kg, four times in one day 1 study [15]
0.03 g/kg/day 1 study [7]
Time of ingestion
Along with breakfast/lunch/dinner or separated by 3–4 h 5 studies [6,15,16,19,20]
Not mentioned 4 studies [16–18,21]
Loading phase
20 g/day (in 4 doses) for a week plus 1 dose of 5 g/day for 9 weeks 1 study [6]
20 g/day (in 4 doses) for a week plus 1 dose of 5 g/day for 5 weeks 1 study [19]
20 g/day (in 4 doses) for a week plus 1 dose of 5 g/day for 6 weeks 1 study [20]
No loading phase 6 studies [7,15–18,21]
Duration of treatment
6 days 3 studies [15,17,21]
7 days 2 studies [16,18]
14 days 1 study [7]
6 weeks 1 study [19]
7 weeks 1 study [20]
9 weeks 1 study [6]
In this context, Table 3 shows the samples included in all studies, which consisted of players who
competed at levels from professional or elite (n = 2) to semiprofessional or amateur teams (n = 7),
who had well-established training habits and whose age group varied from under-17 (n = 2) to senior
team categories (n = 7). In two out of nine studies, Cr was administered based on an individual’s
body mass, while an absolute dose was provided for all participants in seven studies. In this way,
the doses used in each study included values of 30 g/day (3 × 10 g) in one study, 20 g/day (4 × 5 g) in
six studies, 0.3 g/kg, four times in one day in one study, and 0.03 g/day in one study. In five of the
studies included, the time of ingestion of Cr was along with a meal (breakfast, lunch, and dinner) or
separated by 3–4 h, while the others (n = 4) did not mention the time of ingestion. Further, there were
three out of nine studies that used a loading dose of 20 g/day (divided into four doses) for a week and
then a dose of 5 g/day for periods of 1 day, 5 weeks, and 6 weeks, respectively. On the other hand,
there were four studies in which the durations were 6 days, 2 of 7 days, 1 of 14 days, 1 of 6 weeks,
and 1 of 7 weeks, respectively.
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Table 3. Summary of studies included in the systematic review.
AUTHOR/S- YEAR POPULATION INTERVENTION OUTCOMES ANALYZED MAINCONCLUSIONS
Mujika et al., 2000 [17] 17 highly trained male players(20.3 ± 1.4 years) • 5 g, 4 times/day for 6 days
• Countermovement jump
• Repeat sprint ability
• Intermittent endurance test
• ↔
• ↑
• ↔
Bemben et al., 2001 [6] 25 male university players(19.3 ± 0.5 years)
• 5 g, 4 times/day (separated by 3–4 h) for 5 days
• 5 g/day for 9 weeks
• Neuromuscular strength tests
• Anaerobic power test
• Isokinetic test
• ↑
• ↑
• ↔
Cox et al., 2002 [21] 12 elite female players(22.1 ± 5.4 years) • 5 g, 4 times a day for 6 days
• Sprint test
• Agility racing test
• Agility kick drill test
• ↑
• ↑
• ↔
Biwer et al., 2003 [15]
15 (7 males and 8 females)
university players
Age not presented
• 0.3 g/kg, 4 times/day (after breakfast, lunch, and dinner and
before bedtime) for 6 days • Submaximal running test • ↔
Ostojic, 2004 [18] 20 young male players(16.6 ± 1.9 years) • 10 g, 3 times/day for 7 days
• Dribbling test
• Spring test
• Endurance test
• Countermovement jump
• ↑
• ↑
• ↔
• ↑
Claudino et al., 2014 [20] 14 male professional players(18.3 ± 0.9 years)
• 5 g, 4 times/day (breakfast, lunch, dinner, and before bedtime)
for 7 days
• 5 g/day for 6 weeks
• Countermovement jump • ↑
Williams et al., 2014 [16] 16 amateur male players(26.0 ± 4.5 years) • 5 g, 4 times/day (~4 h between doses) for 7 days
• Aerobic (circuit time)
• Speed (12- and 20-m sprint)
• Explosive power (vertical jump)
• ↔
• ↔
• ↔
Ramírez-Campillo et al., 2015 [19] 30 amateur female players(22.9 ± 2.5 years)
• 5 g, 4 times/day (at breakfast, lunch, dinner, and before
bedtime) for 7 days
• 5 g/day (at lunch) for 5 weeks
• Jump test
• Repeated sprint test
• Resistance
• Speed performance in direction change
• ↑
• ↑
• ↔
• ↑
Yañez-Siva et al., 2017 [7] 19 young male players(17.0 ± 0.5 years) • 0.03 g/kg/day (at midday meal) for 14 days
• Maximal power test
• Average output power test
• Fatigue index test
• Total work test
• ↑
• ↑
• ↔
• ↑
↑: statistically significant increase;↔ change with no statistical significance; ↓: statistically significant decrease.
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3.3. Effect on Aerobic Performance Meta-Analysis
Figure 3 shows the overall effect of Cr supplementation on aerobic performance and indicates
that Cr did not produce any significant effect on aerobic performance (SMD, −0.05; 95% CI, −0.37 to
0.28; MSMD, trivial; I2, 0%; p = 0.78). Only Biwer et al. [15] on a submaximal treadmill run interspersed
with high intensity, and Williams et al. [16] on ball-sport endurance and speed test mean circuit time
(s) (aerobic), presented improvements in favor of Cr supplementation.
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3.4. Effect on Phosphagen Metabolism Performance Meta-Analysis
Pre-exercise Cr ingestion produced small but not significant increases in physical performance
in tests main y related to phosphagen metabolism performance (SMD, 0.21; 95% CI, −0.03 to 0.45;
MSMD; mall; I2,43%; = 0.08) (Figure 4). The results indicated that Cr is associated with moderate but
not significant improvements in strength performance (one-repetition maximum (1 RM), peak torqu )
(SMD, 0.50; 95% CI, −0.15 o 1.14; MSMD, moderate; I2,72%; p = 0.13). Concretely, Bemben et al. [6]
showed improvements in favor of Cr on neuromuscular str ngth (1 RM) for bench press, squat,
and power clean; isokinetic strength (peak torque) for quadriceps (180◦/s and 300◦/s); and isokinetic
strength (peak torque) f r quadriceps and ha strings (300◦/s). Likewise, the results presented
trivial and not significant improvements in single jump erform nce (S D, 0.14; 95% CI, −0.12 to
0.39; MSMD, trivial; I2, 0%; p = 0.28). In favor of Cr supplementation, Mujika et al. [17] showed
improvements on a recovery co nter-movement jump (CMJ) c sisting of three jumps (average dat );
Ostojic [18] on a vertical jump cm); Claudino et al. [20] on a CMJ; and Ra í z-Campillo e al. [19]
on peak jump power load (kg), squat jump (cm), and drop jump (40 cm) reactive stre th index
(mm/ms). Similarly, the results showed trivial and not significant improvements in single sprint
velocity SMD, 0.06; 95% CI,−0.70 to 0.81); MSMD, trivial; I2, 62%; p = 0.88). Only Os ojic [18] di play
improveme ts in favor of Cr supple entation on a sp int power test (s). Likewise, the results showed
trivial and no significant imp o ements in the time required to complete agili y tests (SMD, −0.11;
95% CI, −0.83 to 0.61; MSMD, trivial; I2, 0%; p = 0.77). Only Cox e al. [21] presented improvements in
favor of Cr supplementation on a simulated match play test/agility run.
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3.5. Effect on Anaerobic Performance Meta-Analysis
However, a large and significant, potentially ergogenic effect of Cr was found in those tests which
were mainly related to anaerobic performance (SMD, 1.23; 95% CI 0.55–1.91; MSMD, large; I2, 81%;
p <0.001) (Figure 5). Cr supplementation demonstrated a large and significant effect on the Wingate
test (SMD, 2.26; 95% CI, 1.40–3.11; MSMD, large; I2, 72%; p <0.001). Also, Bemben et al. [6] showed an
improvement in anaerobic power and capacity measured by the Wingate test, and Yañez-Silva et al. [7]
presented improvements in favor of Cr supplementation in peak and mean power output (W/k) and
total work (J/kg) measured by the Wingate test. On the other hand, the results showed small but not
significant effects on repeated spring ability performance (SMD, 0.26; 95% CI –0.13 to 0.65; MSMD,
trivial; I2, 0%; p = 0.20). Mujika et al. [17] presented an improvement in favor of Cr supplementation
on a repeated sprint test consisting of six maximal 15-m runs with a 30-s recovery, Cox et al. [21] on
a simulated match play test/20-m repeated sprint time, and Ramírez-Campillo et al. [19] on a running
anaerobic sprint test.
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4. Discussio
The main purpose of this systematic review and meta-analysis was to summarize the effects of
Cr supplementation on physical performance tests related to aerobic, phosphagen, and anaerobic
metabolisms in soccer players.
The main results indicate that Cr supplementation with 20–30 g/day ingested for 6–7 days
followed by 5 g/day for 1–9 weeks led to significant improvements in anaerobic performance. On the
other hand, Cr supplementation showed trivial to small but not significant effects on tests related to
aerobic and phosphagen metabolisms. Thus, this meta-analysis suggests that Cr supplementation
could be an ergogenic aid to improve the anaerobic performance of soccer players.
The best method of increasing muscle Cr stores appears to be Cr supplementation with a loading
phase of 0.3 g/kg/day (~20–30g/day) for 3–5 days, followed by 3–5 g/day to maintain elevated Cr
stores [31]. Likewise, Cr supplementation with 0.03 g/kg/day (~2–3 g/day) will increase muscle Cr
stores over a 3–4 weeks period [31]. These protocols are important since Cr levels in the human body
can be elevated for up to 30 days [31,32]. Likewise, it has to be taken into to account that about 20–30%
of individuals do not respond to Cr loading [33]. However, the articles included in this review and
meta-analysis did not contain any comments about responders or non-responders when soccer players
were supplemented with Cr. Therefore, although the studies that were included in this review and
meta-analysis complied with the protocols aimed at increasing muscle Cr stores, to our knowledge,
it is impossible to know if the results were affected by players who were responders or non-responders
to Cr loading.
The physiological demands of soccer have changed dramatically over time [34]. Currently, soccer
players cover greater distances, perform more explosive actions, and compete at higher intensities
than ever before [35,36], and sports science has played a key role in these advances [37]. In particular,
nutrition has been integral in the search for and use of supplements that allow players to perform
better at higher intensities [8]. In this sense, Cr is one of the most studied supplements in athletes,
given that it produces the ability to resynthesize the adenosine triphosphate (ATP) that is used while
exercising and, consequently, to maintain maximal exercise increases [31]. Thus, Cr supplementation
could lead to greater training adaptations due to the higher quality of and capacity for exercise, as well
as a quicker recovery period [38]. For this reason, Cr could be recommended for the improvement of
soccer physical performance because it is involved in different metabolic pathways [39].
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4.1. Effect on Aerobic Performance
Soccer requires a great aerobic capacity because of the duration of a match (90 min and sometimes
30 min of extra time) [40]. In addition, a relationship between the aerobic power and competitive
classification, the competitive level of the team, and the distance covered during the match has been
demonstrated [41,42]. For this reason, looking for ways to improve this capacity throughout the season
is essential to maintaining a high level of performance. In this sense, oral supplementation with Cr
for 7 days could improve aerobic performance in elite athletes [43], since it has been shown that after
Cr supplementation, there is an increase in PCr content at rest in muscle fiber type I [44]. In addition
to a reduction in the use of muscle PCr, there is a lower accumulation of inorganic phosphate (Pi)
as well as a decrease in muscle pH during low-intensity exercises after loading Cr, which would
indicate a delay of fatigue during prolonged periods of resistance work [45]. However, these results
are controversial, since in most studies, Cr supplementation did not improve the ability to perform
long-term submaximal exercise [46,47], nor did it modify the maximum absorption of oxygen and
the circulatory, metabolic, and ventilatory responses to a progressive exercise test [48,49]. In this line,
Mujika et al. [17], Ostojic [18], and Biwer et al. [15] did not observe changes in aerobic capacity in
both male and female soccer players and young soccer players after supplementation with 20 and
30 g/day of Cr for 6–7 days. Further, Ramirez et al. did not find improvements in aerobic performance
after a 6-week supplementation with Cr in female amateur players [19]. Therefore, although aerobic
metabolism plays a major role in soccer, given that it provides 90% of the energy used during soccer
match play [50], the results obtained in this meta-analysis indicate that Cr supplementation in soccer
players has no benefits in improving aerobic performance. Highly trained aerobic metabolism is
dependent on intramuscular triglycerides and not PCr or muscle glycogen [51]. For that reason,
Cr supplementation could not enhance aerobic performance [52].
4.2. Effect on Phosphagen Metabolism Performance
Anaerobic power and explosive force are also essential components of soccer performance since
they allow players to execute the constant muscular adjustments necessary to perform different actions,
as well as allowing actions such as jumps, shots, short sprints, or agility actions [53]. In this sense,
the power of the lower extremities as a product of neuromuscular stimulus has been associated
with speed performance in soccer players [54]. Thus, several studies have examined the potential
associations among the ability to sprint and several measures of strength and power in different
exercises related to soccer performance [54,55]. It seems reasonable to expect soccer players to benefit
from Cr supplementation because most of their activity in this field involves powerful and explosive
anaerobic movements that require the immediate release of energy provided by ATP and the rapid
re-synthesis of ATP from adenosine diphosphate (ADP) and PCr. In this way, the results obtained in
the meta-analysis indicated that the intake of Cr prior to exercise was associated with a small but not
significant increase in physical performance in those tests that were mainly related to phosphagen
metabolism performance. Specifically, the results showed moderate but not significant effects on
different strength exercises (1 RM and peak torque) performed by 25 college football players after 6 days
of supplementation with 20 g/day of Cr [6]. However, only trivial and nonsignificant improvements
were seen in single jump performance, single sprint speed, or the time required to complete agility tests.
Although this type of activity requires ATP, its re-synthesis is not decisive for jumping or sprinting
because they are more dependent on neuromuscular performance [56]. In addition, the short duration
of the Cr supplementation protocols used (5 g, four times) in this meta-analysis could also have
influenced in the results.
4.3. Effect on Anaerobic Performance
It is currently recognized that the most decisive actions during soccer practice are related
to anaerobic metabolism [57]. In this sense, anaerobic power, together with the specific skills of
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the sport, seem to be the determinants of high performance [58]. Although there are different
tests to assess anaerobic power and, therefore, the performance of the anaerobic metabolism of
a player, the most important test used in the field of soccer exercise physiology is the gold standard
anaerobic Wingate test [59,60]. For that reason, the Wingate test has been used to validate field
tests in this sport [61,62] because it has been positively correlated with better performance during
soccer matches [63]. In addition, it has been used to monitor the effectiveness of different training
programs [64,65]. Therefore, seeking better adaptations in anaerobic metabolism seems to favor
the performance of soccer players. In this sense, Cr seems to be a good ergogenic aid to produce
improvements in test performances in which anaerobic metabolism predominates, as it has been
demonstrated in this meta-analysis. Specifically, both Yañez-Silva et al. [7] and Bemben et al. [6]
showed that short-term Cr supplementation (6–7 days) improved maximum and average anaerobic
power, as well as the total work measured by the Wingate test in both young and university players.
The positive effect of Cr supplementation on activities related to anaerobic metabolism may be due
to the benefits that Cr has on the muscle glycogen store [5]. This effect is thought to be the result
of increased cell size due to Cr-induced water retention and is associated with the upregulation of
signaling pathways mediating glycogen and protein synthesis, namely, 5’AMP-activated protein kinase
(AMPK) and mechanistic target of rapamycin (mTOR)-mediated signaling [38].
4.4. Strengths, Limitations, and Future Lines of Research
The main limitation of this systematic review and meta-analysis is the scarcity of studies carried
out in relation to Cr supplementation in soccer players (n = 9), which forced us to carry out the
analyses by mixing data of both sexes, different competitive levels, and different research protocols.
Thus, it should be noted that neither the dose nor the duration of Cr supplementation protocol has
been taken into account. In fact, studies were mixed, in which Cr supplementation used short-term
(5–7 days) and long-term (6–7 weeks) protocols, which may have influenced the results. The protocols
used in some studies [16,21] may have also influenced the results obtained in this meta-analysis
because some physical performance tests were joined together as a field test simulating match play
(not isolated), which probably could affect the metabolic pathway of the participants during exercise
and, consequently, the performance obtained in each test. However, one important strength is that
the proportion of the total variation that was attributable to the heterogeneity observed in many of
the physical tests analyzed was zero (I2 = 0%). Another limitation of this systematic review and
meta-analysis is related to the impossibility of presenting body composition data that would have
helped us interpret the results.
Future research projects could include the use of a general protocol of Cr supplementation in
different skills related to soccer performance that involve different metabolisms in both male and
female soccer players, as well as in different levels of competition.
4.5. Practical Applications
Generally, Cr supplementation has been used during the competitive season (in case of fatigue)
in order to sustain adequate levels of Cr, PCr, and/or glycogen in the muscles and also to improve
muscle repair [66]. However, Cr supplementation could be specially used in those periods in which
the priority of training is to improve anaerobic power or enhance muscular power and adaptation,
such as during pre-season, winter break, or a summer-like opportunity window [67]. In addition,
Cr supplementation could be particularly useful for those team members who, due to their position in
the field and the match characteristics, are specially involved in actions that demand high anaerobic
power. Related to this point, it should be kept in mind that some individuals may respond more
(or less) to Cr supplementation than others because they have lower endogenous muscle Cr content
and/or a greater amount of type II fibers [66]. Consequently, effects should be evaluated and/or
measured individually in each soccer player, interrupting supplementation in athletes who do not
respond to it (likely “low-responders”) or report different effects than expected, given that about
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20–30% of individuals do not respond to Cr loading [33]. Finally, but no less importantly, soccer
players could also benefit from Cr supplementation to augment their training capacity (increase in
load and/or performance) when they return to normal training after an injury, which could prevent
reinjury due to the physical demands of soccer training or competition. Regardless, future studies
should analyze the individual and optimal load for each player based on personalized needs [68].
5. Conclusions
The results of this systematic review and meta-analysis have shown that Cr supplementation
improved the performance of physical tests related to anaerobic metabolism, especially anaerobic
power, in soccer players. The effective dose of Cr supplementation to obtain positive effects should
include a load dose of 20–30 g/day, divided 3–4 times a day, ingested for 6–7 days, and followed by
5 g/day for 9 weeks or a low dose of 3 mg/kg/day for 14 days or more.
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